Evidence map›Paper›PMID 29325279›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2017

[Characteristics of IgH-CDR3 repertoire of peripheral B cells in a patient with primary biliary cholangitis: a preliminary study using high-throughput sequencing].

D T Zhao, C L Guo, H P Yan, H Y Liao, Y M Liu, H P Zhang, L S An, C Y Huang, Y Han, Y Zhao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

D T ZhaoClinical Research Center for Autoimmune Liver Disease & Clinical Laboratory Center, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China.
C L GuoNational Research Institute for Family Planning, Beijing 100081, China.
H P YanClinical Research Center for Autoimmune Liver Disease & Clinical Laboratory Center, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China.
H Y LiaoDepartment of Liver Disease Immunology, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China.
Y M LiuDepartment of Liver Disease Immunology, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China.
H P ZhangClinical Research Center for Autoimmune Liver Disease & Clinical Laboratory Center, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China.
L S AnNational Research Institute for Family Planning, Beijing 100081, China.
C Y HuangDepartment of Liver Disease Immunology, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China.
Y HanDepartment of Liver Disease Immunology, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China.
Y ZhaoClinical Research Center for Autoimmune Liver Disease & Clinical Laboratory Center, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

B-LymphocytesComplementarity Determining RegionsHigh-Throughput Nucleotide SequencingImmunoglobulin Heavy ChainsCholangitisHumansComplementarity Determining RegionsImmunoglobulin Heavy ChainsB cell receptorIGH-CDR3 repertoireLiver cirrhosis, biliary

Identifiers

PMID29325279
PMCPMC12770636

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.